BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/4/2020 8:47:30 AM | Browse: 617 | Download: 1239
 |
Received |
|
2020-07-04 11:58 |
|
Peer-Review Started |
|
2020-07-04 11:58 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2020-07-24 03:12 |
|
Revised |
|
2020-07-29 14:24 |
|
Second Decision |
|
2020-08-24 12:11 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2020-08-25 23:06 |
|
Articles in Press |
|
2020-08-25 23:06 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2020-09-01 07:25 |
|
Publish the Manuscript Online |
|
2020-09-04 08:47 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Medicine, Research & Experimental |
| Manuscript Type |
Review |
| Article Title |
Autoimmunity as the comet tail of COVID-19 pandemic
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Rossella Talotta and Erle Robertson |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Rossella Talotta, MD, PhD, Senior Researcher, Department of Clinical and Experimental Medicine, Rheumatology Unit, AOU “Gaetano Martino”, University of Messina, via Consolare Valeria 1, Messina 98100, Italy. talotta1@virgilio.it |
| Key Words |
COVID-19; SARS-CoV-2; Autoimmunity; Autoimmune diseases; Rheumatic diseases; Host-virus interaction |
| Core Tip |
The immune system plays a central role in coronavirus disease 2019 (COVID-19), being responsible for clinical manifestations and prognosis. Hyper-activation of the immune response against severe acute respiratory syndrome coronavirus 2 may result, in some cases, in development of unwanted autoimmune disorders. COVID-19 has been associated with immune-mediated systemic or organ-selective manifestations, some of which fulfill the diagnostic or classification criteria of specific autoimmune diseases. Though it is still unknown whether these medical conditions represent transitory post-infectious epiphenomena, the use of therapeutic agents targeting the immune system may perhaps prevent their chronicization which leads to development of autoimmune diseases. |
| Publish Date |
2020-09-04 08:47 |
| Citation |
Talotta R, Robertson E. Autoimmunity as the comet tail of COVID-19 pandemic. World J Clin Cases 2020; 8(17): 3621-3644 |
| URL |
https://www.wjgnet.com/2307-8960/full/v8/i17/3621.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v8.i17.3621 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
